Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
Enterovirus 71 (EV71) is one of the pathogens of hand, foot, and mouth disease and various neurological symptoms including fatal encephalitis in young children. There are no specific therapies available. In this study, I focused on the anti-EV71 compound, NF449. I clarified how NF449 inhibits EV71 replication in vitro. I found that NF449 interacts with the EV71 capsid and prevents virus attachment to the receptor molecules on the cell surface. This work provides information that may facilitate development of improved antiviral compounds that block the attachment of EV71 to cellular receptors.
|